Metronics Introduces Brain-Stimulation Implants
By wchung | 09 Jun, 2026
Medtronic Inc. said Tuesday it began marketing two surgically implanted devices that are intended to help relieve symptoms for patients with neurodegenerative diseases.
The Minneapolis company said it is now marketing the Activa RC and Activa PC neurostimulators in Canada, and the first implantation of the new device has already taken place. The products are intended to reduce symptoms by stimulating the brain electronically.
Medtronic said the devices have new programming options, are smaller than its older models, and feature rechargeable batteries that can last up to nine years before a replacement is needed. The neurostimulators are used to treat conditions like Parkinson’s disease and tremors.
In afternoon trading, Medtronic shares added 65 cents to $43.09.
2/16/2010 1:30 PM NEW YORK (AP)
Recent Articles
- China's May Export Growth Surges on AI Wave
- Trump Greeted with Boos at NBA Finals in MSG
- Trump's $100,000 H-1B Visa Fee Declared Unlawful
- OpenAI Files for IPO on Heels of Anthropic
- Bedtime Story: The Scholar Who Entered a Painting
- Sunny Mehta’s Poker Past Highlights Eccentric Path to Devils GM
- First Filipino NBA Champion, LPGA Korean Duo, BYU’s Akina Honored
- China May Exports Pegged for Strong Growth on Front-Loaded Orders, Chip Demand
- China's Global E-Commerce Slides as Iran War Lifts Costs, Dampens Demand
- S. Korea to Seek Priority Supply of Nvidia Vera Rubin GPUs